In the following study, researchers investigated the effects of BP-1-102, a novel inhibitor of signal transducer and activator of transcription 3 (STAT3), on AGS cells. Flow cytometric analysis and Western blot analysis revealed that BP-1-102 induces apoptosis and inhibited the phosphorylation of STAT3 and its target genes in a time- and dose-dependent manner. These results indicate that BP-1-102 has the potential to be used as an antitumor agent in AGS cells through the modulation of STAT3 signaling pathways. [LINK]
The AGS cell line originated in 1979 from the stomach tissue of a 54-year-old Caucasian female who had been diagnosed with gastric adenocarcinoma. AGS cells are tumorigenic, hyperdiploid, and have a modal chromosome number of 49. AGS exhibits adherent cultural properties and has an epithelial morphology. The AGS cell line is a good host for the study of stomach cancer and other stomach infections using in vivo and in vitro transfection methods. An AGS Transfection Reagent to transfect AGS cells is commercially available from Altogen Biosystems , and an AGS xenograft murine model is displayed here .
Comments
Post a Comment